A. Praud-Tabaries et al. / Tetrahedron Letters 50 (2009) 1645–1648
1647
Table 2
Synthesis of selected 1,2,3-triazolesa
N
R
N
N
Br
R
n
n
Compounds a(Z),b(E)
n
R
Yield (%)
Z/E ratio
3a,b
4a,b
5a,b
6a,b
7a,b
8a,b
9a,b
10a,b
11a,b
12a,b
1
1
1
1
1
2
2
2
2
2
2-Methoxy
3-Methoxy
4-Methoxy
3,5-Dimethoxy
3-Hydroxy
2-Methoxy
3-Methoxy
4-Methoxy
3,5-Dimethoxy
3-Hydroxy
83
92
68
45
94
78
69
94
82
88
20/80
36/64
38/62
41/59
58/42
37/63
40/60
36/64
35/65
35/65
a
16
All experiments were achieved in the same conditions of concentration of reactants, catalyst, volume of solvents as referenced for entry 1 in Ref.
.
the final composition. As observed (Table 2), independently of the
structural differences within the azide precursors (geranyl or far-
nesyl), the 1,2,3-triazole derivatives were obtained as Z/E mixtures
in good to excellent yields.
All compounds were tested as Z/E mixtures at a concentration of
500 lM for their capacity to inhibit biofilm formation by Pseudoal-
more, the potential of the Cu(I)-catalyzed Huisgen reaction as a
successful strategy to explore new diversity space and address
the structural decoration of privileged scaffolds has been estab-
lished in this area. Although we did not obtain any antibacterial
activity with the newly constructed terpenoid-like compounds, it
can be concluded that this class of compounds provide interesting
lead in our search for new potential inhibitors of bacterial biofilm
formation that should be used as environmentally-friendly anti-
fouling biocides. Further studies in this field by using others bacte-
rial strains are actually under way.
teromonas sp. D41. (Table 3).17 Farnesol (the parent sesquiterpene
of 8–12 and SEANINEÒ (a commercial biocide used in antifouling
coatings) were used as references. The results showed that all far-
nesyl derivatives presented mild to good anti-adhesion activities,
while only two geranyl derivatives were potentially active.
The most active compounds 5a,b and 11a,b were selected to
evaluate the EC50 of each isomer (EC50 is expressed as the effective
concentration to inhibit 50% of the bacterial adhesion). Results
showed that both isomers of the farnesyl derivative are active.
All compounds were also evaluated as the Z/E mixtures for their
potential antibacterial activities, in order to correlate inhibition
of biofilm to an antibacterial activity. Using the disk diffusion assay
methods,18 compounds were tested for their antibacterial activities
against various strains of bacteria, including Pseudoalteromonas sp.
(D41), Pseudomonas aeruginosa (ATCC A22), Staphylococcus aureus
(ATCC 53.156), Bacillus cereus (ATCC 78.3), and Escherichia coli
(ATCC 54.8 T). Interestingly, no significant inhibitory activities
were observed when compared to norfloxacin.
Acknowledgment
The pseudoalteromonas sp. strain was gracefully supplied by
IFREMER; Service Interfaces et Capteurs, IFREMER Brest, France.
References and notes
1. Omae, A. Chem. Rev. 2003, 103, 3431; Haras, D. Matériaux Techn. 2005, 93, 27.
2. Fusetani, N. Nat. Prod. Rep. 2004, 21, 94.
3. Culioli, G.; Ortalo-Magne, A.; Valls, A.; Hellio, C.; Clare, S.; Piovetti, L. J. Nat Prod.
2008, 71, 1121.
4. Fisch, K.-M.; Böhm, V.; Wright, A.-D.; König, G.-M. J. Nat. Prod. 2003, 66, 968.
5. Bodet, C.; Epifano, F.; Genovese, S.; Curini, M.; Grenier, D. Eur. J. Med. Chem.
2008, 43, 1612.
6. Rodrıguez-Borges, J.-E.; Goncalves, S.; Vale, M.-L.; Garcia-Mera, X.; Coelho, A.;
Sotelo, E. J. Comb. Chem. 2008, 10, 372; Zhang, J.; Chen, H.-N.; Chiang, F.-I.;
Takemoto, J.-Y.; Bensaci, M.; Chang, C.-W.-T. J. Comb. Chem. 2007, 9, 17; Tornoe,
C.-W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, 3057; Tornoe, C.-W.;
Meldal, M. In Peptides 2001, Lebl, M.; Houghten, R. A., Eds.; Proc. Am. Pept. Symp.;
American Peptide Society: San Diego, and Kluwer Academic, 2001; pp 263–264.;
Meldal, M.; Tornøe, C. W. Chem. Rev. 2008, 108, 2952; Rostovtsev,
V.-V.; Green, L.-G.; Fokin, V.-V.; Sharpless, K.-B. Angew. Chem., Int. Ed. 2002, 41,
2596;Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.;Wiley:New
York, 1984; pp 1–176.
7. Rogers, S.-A.; Melander, C. Angew. Chem., Int. Ed. 2008, 47, 5229.
8. Genin, M.-J.; Allwine, D.-A.; Anderson, D.-J.; Barbachyn, M.-R.; Emmert, E.;
Garmon, S.-A.; Graber, D.-R.; Grega, K.-C.; Hester, J.-B.; Hutchinson, D.-K.;
Morris, J.-R.; Reischer, J.-C.; Ford, W.; Zurenko, G.-E.; Hamel, J.-C.;
Schaadt, R.-D.; Stapert, D.; Yagi, B.-H. J. Med. Chem. 2000, 43, 953;
Holla, B.-S.; Mahalinga, M.; Karthikeyan, M.-S.; Poojary, B.; Akberali, P.-M.;
Kumari, N.-S. Eur. J. Med. Chem. 2005, 40, 1173.
9. Chen, M.-D.; Lu, S.-J.; Yuag, G.-P.; Yang, S.-Y.; Du, X.-L. Heterocycl. Commun.
2000, 6, 421; Sherement, E.-A.; Tomanov, R.-I.; Trukhin, E.-V.; Berestovitskaya,
V.-M. Russ. J. Org. Chem. 2004, 40, 594.
10. Danoun, S.; Baziard-Mouysset, G.; Stigliani, J.; Payard, M.; Selkti, M.; Viossat, B.;
Tomas, A. Heterocycl. Commun. 1998, 4, 45.
11. Feldman, A.-K.; Colasson, B.; Sharpless, K. B.; Fokin, V.-V. J. Am. Chem. Soc. 2005,
127, 13444; Padwa, A.; Marcus, M. Tetrahedron Lett. 1997, 38, 5087.
12. 1-Geranyl-4-methoxymethyl-1H-1,2,3-triazole (1a): Yellow oil, MS (ESI), 250
(M+1), 272(M+23), 1H NMR (400 MHz, CDCl3) d 1.58 (s, 3H, CH3), 1.66 (s, 3H,
CH3), 1.76 (s, 3H, CH3), 2.12 (m, 4H), 3.39 (s, 3H, OCH3), 4.55 (s, 2H), 4.94
In summary, a simple and efficient procedure allowing the rapid
assembly of libraries of bioactive valuable 1,2,3-triazoles contain-
ing terpenoid mimetic structures has been developed. Further-
Table 3
Pseudoalteromonas sp. D41 biofilm inhibition of compounds 1–12
Compoundsa
(%) of adhesionb
EC50 (lM)
Z/E (a,b)
E (a)
Z (b)
5a,b
7a,b
8a,b
9a,b
10a,b
11a,b
12a,b
Farnesol
SeanineÒ
3
30
25
15 39
46
0
34
25
19
8
6
7
400.0 5.9
298.0 1.2
71.0 1.2
188.0 1.2
7
7
2
9
6
99.0 1.2
53.0 1.2
188.0 1.2
135.0 2.0
a
No activity was observed with other compounds (3, 4, 6).
Percentage of adhesion at a concentration of 500 lM (% of adhesion).
b